{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:10:46Z","timestamp":1783537846076,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:31:05Z","timestamp":1525912265000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Nociceptin\/orphanin FQ opioid peptide (NOP) receptor and \u00b5-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain"],"prefix":"10.1016","volume":"832","author":[{"given":"Klaus","family":"Schiene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Linz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Frosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Tzschentke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Christoph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.05.005_bib1","series-title":"Biopharmaceutical Statistics for Drug Development","author":"Buncher","year":"1987"},{"key":"10.1016\/j.ejphar.2018.05.005_bib2","unstructured":"Bundesministerium f\u00fcr Ern\u00e4hrung und Landwirtschaft, 1972. Tierschutzgesetz. \u3008http:\/\/www.gesetze-im-internet.de\/tierschg\/\u3009. (Accessed 9 February 2016)."},{"key":"10.1016\/j.ejphar.2018.05.005_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3959(92)90133-V","article-title":"A limited arthritic model for chronic pain studies in the rat","volume":"48","author":"Butler","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.05.005_bib4","series-title":"Research and Development of Opioid-related Ligands","first-page":"275","article-title":"Medicinal chemistry, pharmacology, and biological actions of peptide ligands selective for the nociceptin\/orphanin FQ receptor","author":"Calo","year":"2013"},{"key":"10.1016\/j.ejphar.2018.05.005_bib5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1529-8027.2006.0093.x","article-title":"Nociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processing","volume":"11","author":"Chen","year":"2006","journal-title":"J. Peripher Nerv. Syst."},{"key":"10.1016\/j.ejphar.2018.05.005_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jnr.21272","article-title":"Activation of the nociceptin opioid system in rat sensory neurons produces antinociceptive effects in inflammatory pain: involvement of inflammatory mediators","volume":"85","author":"Chen","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2018.05.005_bib7","series-title":"Wissenschaftliche Tabellen Geigy \u2013 Statistik","author":"Ciba-Geigy","year":"1980"},{"key":"10.1016\/j.ejphar.2018.05.005_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bph.12612","article-title":"Challenges for opioid receptor nomenclature: iuphar Review 9","volume":"172","author":"Cox","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.05.005_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.112.194308","article-title":"Roles of mu-opioid receptors and nociceptin\/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates","volume":"343","author":"Cremeans","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.05.005_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/ALN.0000000000001529","article-title":"Respiratory effects of the nociceptin\/orphanin FQ peptide and opioid receptor agonist, cebranopadol, in healthy human volunteers","volume":"126","author":"Dahan","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2018.05.005_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/aet128","article-title":"Neuroinflammation and the generation of neuropathic pain","volume":"111","author":"Ellis","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.05.005_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(98)00430-3","article-title":"Nociceptin\/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation","volume":"250","author":"Jia","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.05.005_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar2147","article-title":"Arthritis and pain. Current approaches in the treatment of arthritic pain","volume":"9","author":"Kidd","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2018.05.005_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1124\/jpet.114.213694","article-title":"Cebranopadol: a novel potent analgesic nociceptin\/orphanin FQ peptide and opioid receptor agonist","volume":"349","author":"Linz","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.05.005_bib15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/ALN.0000000000001530","article-title":"Opioid-type respiratory depressant side effects of cebranopadol in rats are limited by its nociceptin\/orphanin FQ peptide receptor agonist activity","volume":"126","author":"Linz","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2018.05.005_bib16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2018.05.005_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0304-3959(82)90003-3","article-title":"Electrophysiological characteristics of dorsal horn cells in rats with cutaneous inflammation resulting from chronic arthritis","volume":"13","author":"Menetrey","year":"1982","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.05.005_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(00)00520-3","article-title":"In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist","volume":"402","author":"Ozaki","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.05.005_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/art.37739","article-title":"Central pain mechanisms in the rheumatic diseases: future directions","volume":"65","author":"Phillips","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ejphar.2018.05.005_bib20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/jm991129q","article-title":"High-affinity, non-peptide agonists for the ORL1 (orphanin FQ\/nociceptin) receptor","volume":"43","author":"R\u00f6ver","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.05.005_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2018.03.008","article-title":"Selectivity profiling of NOP, MOP, DOP and KOP receptor antagonists in the rat spinal nerve ligation model of mononeuropathic pain","volume":"827","author":"Rutten","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.05.005_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","volume":"16","author":"Schaible","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejphar.2018.05.005_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.111.181263","article-title":"Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain","volume":"339","author":"Schiene","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.05.005_bib24","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1111\/bph.12744","article-title":"Functional plasticity of the N\/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists","volume":"171","author":"Schr\u00f6der","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.05.005_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/ml500117c","article-title":"Discovery of a potent analgesic NOP and opioid receptor agonist: cebranopadol","volume":"5","author":"Schunk","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2018.05.005_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejpain.2005.08.003","article-title":"An animal model of chronic inflammatory pain: pharmacological and temporal differentiation from acute models","volume":"10","author":"Wilson","year":"2006","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.ejphar.2018.05.005_bib27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joca.2010.01.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009","volume":"18","author":"Zhang","year":"2010","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejphar.2018.05.005_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T22:46:35Z","timestamp":1561070795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918302619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S0014299918302619"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nociceptin\/orphanin FQ opioid peptide (NOP) receptor and \u00b5-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}